The HPV Vaccine is Working

New research out of Scotland found that routine HPV vaccinations has led to a “dramatic” drop in cervical disease later in life.

HPV Vaccine / Image: Tennessean
HPV Vaccine / Image: Tennessean

A recent BBC article contained some uplifting news regarding the human papillomavirus (HPV) and cervical cancer. Researchers in Scotland found that in the 10 years the HPV vaccine has been used, it has exceeded expectations by decreasing cases of pre-cancerous cells by 90%. The vaccine is routinely given to schoolgirls in the UK at the age of 12 or 13. There are more than 100 types of HPV, and it doesn’t always cause symptoms, but 99.7% of cervical cancers are linked to HPV infection.

Interestingly, unvaccinated women also experienced a decrease in disease, a phenomenon known as herd immunity. It occurs when a large percentage of a population becomes immune to infection, which in turn protects other individuals who are not immune.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?